Filing Details
- Accession Number:
- 0001078782-13-002392
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-04 12:52:34
- Reporting Period:
- 2013-11-25
- Filing Date:
- 2013-12-04
- Accepted Time:
- 2013-12-04 12:52:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
93314 | Volitionrx Ltd | VNRX | In Vitro & In Vivo Diagnostic Substances (2835) | 911949078 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579377 | Archibald Guy Innes | 1 Scotts Road, #24-05 Shaw Centre Singapore U0 228208 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-25 | 132,246 | $271,102.70 | 1,064,341 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2013-12-02 | 4,878 | $9,999.90 | 1,069,219 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 5 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | WARRANT | Acquisiton | 2013-11-25 | 132,246 | $271,102.70 | 132,246 | $2.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
337,067 | 2013-11-25 | 2018-11-25 | No | 4 | P | Direct |
Footnotes
- A total of 132,246 Units (1 Unit = 1 common share + 1 warrant to purchase 1 common share) were acquired on November 25, 2013, of which 121,952 Units were purchased at a cost basis of $2.05 per Unit and 10,294 Units were acquired pursuant to the settlement of an existing debt between the Company and Guy Archibald Innes valued at $21,102.70.
- The 4,878 shares were purchased at a cost basis of $2.05 per share.